title: Suppression of alloreactivity and allograft rejection by SP600125, a small molecule inhibitor of c-Jun N-terminal kinase.
abstract: BACKGROUND
  c-Jun N-terminal kinase (JNK) is reported to play crucial roles in T-cell activation and differentiation, and SP600125 is a small molecule that inhibits JNK. The aim of this study was to examine immunosuppressive action of this compound.
  
  
  METHODS
  Rat heterotopic heart transplantation, popliteal lymph node (PLN) hyperplasia bioassay and lymphocyte proliferation assay.
  
  
  RESULTS
  SP600125 treatment reduced histological rejection, and dose-dependently extended median survival time of cardiac allografts from 7 days (vehicle) up to 20 days (40 mg/kg/day). Alloantigen-induced PLN hyperplasia was also inhibited by SP600125 in a similar fashion. SP600125 suppressed mixed lymphocyte reaction and OX52-positive lymphocyte proliferation (IC50: 1.5-5.7 microM). Thus, SP600125 inhibits both T-lymphocyte expansion in vitro and T-cell-mediated alloimmune responses in vivo. In addition, SP600125 interacted with cyclosporine additively to prolong cardiac allograft survival.
  
  
  CONCLUSIONS
  Our data provide the first evidence indicating the potential for JNK as a therapeutic target to inhibit the alloimmune response.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tabata
authors.forename: Masayuki
authors.initials: M
authors.lastname: Morikawa
authors.forename: Masahiro
authors.initials: M
authors.lastname: Miyajima
authors.forename: Brydon L
authors.initials: BL
authors.lastname: Bennett
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Satoh
authors.forename: Jianhua
authors.initials: J
authors.lastname: Huang
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Tamura
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Sato
authors.forename: Tomio
authors.initials: T
authors.lastname: Abe
mesh_terms: D000818:Animals; D000873:Anthracenes / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D007519:Isoantigens / Q000276:immunology; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors*; D008198:Lymph Nodes / Q000473:pathology; D008213:Lymphocyte Activation; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous / Q000502:physiology*
chemical_list: D000873:Anthracenes; D004791:Enzyme Inhibitors; D007519:Isoantigens; C432165:pyrazolanthrone; D048031:JNK Mitogen-Activated Protein Kinases